CONNECTICUT "DEFINITION OF DRUG DOSAGE FORMS" ACT WOULD PROHIBIT PHARMACIST SUBSTITUTION OF "UNIQUE DELIVERY SYSTEM" DRUGS; CALIF. CONSIDERS SIMILAR BILL
A Connecticut Act "Concerning the Definition of Drug Dosage Forms" would prohibit a pharmacist from substituting any drug or product if the originally prescribed product utilizes a "unique delivery system technology." Governor Weicker (Ind.) received the bill May 2 after it passed both Houses of the state legislature; a signature was required by May 7 for it to become law. The Connecticut bill is modeled after an Oregon bill that became law last year.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth